Halyard Health, Inc. (HYH) Stake Raised by TIAA CREF Investment Management LLC

TIAA CREF Investment Management LLC grew its position in shares of Halyard Health, Inc. (NYSE:HYH) by 35.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 202,901 shares of the medical instruments supplier’s stock after buying an additional 52,881 shares during the quarter. TIAA CREF Investment Management LLC owned 0.43% of Halyard Health worth $7,970,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Riverhead Capital Management LLC grew its holdings in shares of Halyard Health by 88.1% during the second quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock valued at $126,000 after buying an additional 1,497 shares during the last quarter. Victory Capital Management Inc. purchased a new stake in shares of Halyard Health during the first quarter valued at approximately $153,000. LS Investment Advisors LLC grew its holdings in shares of Halyard Health by 16.1% during the second quarter. LS Investment Advisors LLC now owns 4,017 shares of the medical instruments supplier’s stock valued at $158,000 after buying an additional 556 shares during the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of Halyard Health by 102.5% during the first quarter. Tower Research Capital LLC TRC now owns 4,836 shares of the medical instruments supplier’s stock valued at $184,000 after buying an additional 2,448 shares during the last quarter. Finally, Blair William & Co. IL purchased a new stake in shares of Halyard Health during the first quarter valued at approximately $209,000. Hedge funds and other institutional investors own 91.02% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Halyard Health, Inc. (HYH) Stake Raised by TIAA CREF Investment Management LLC” was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://ledgergazette.com/2017/10/10/halyard-health-inc-hyh-stake-raised-by-tiaa-cref-investment-management-llc.html.

A number of equities research analysts have recently commented on HYH shares. BidaskClub upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a report on Saturday, August 19th. Deutsche Bank AG increased their price target on shares of Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a report on Thursday, August 3rd. Zacks Investment Research cut shares of Halyard Health from a “buy” rating to a “sell” rating in a report on Wednesday, October 4th. Stifel Nicolaus reiterated a “buy” rating and set a $45.00 price target on shares of Halyard Health in a report on Thursday, September 21st. Finally, Stephens upgraded shares of Halyard Health from an “equal weight” rating to an “overweight” rating in a report on Thursday, August 3rd. One analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company’s stock. Halyard Health has a consensus rating of “Buy” and a consensus price target of $42.25.

Shares of Halyard Health, Inc. (NYSE HYH) opened at 44.18 on Tuesday. Halyard Health, Inc. has a 12-month low of $31.59 and a 12-month high of $46.63. The stock’s 50 day moving average is $45.21 and its 200-day moving average is $40.37. The stock has a market cap of $2.06 billion, a PE ratio of 42.48 and a beta of 1.75.

Halyard Health (NYSE:HYH) last released its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.14. The company had revenue of $399.20 million for the quarter, compared to

Other large investors have also recently bought and sold shares of the company. Riverhead Capital Management LLC grew its holdings in shares of Halyard Health by 88.1% during the second quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock valued at $126,000 after buying an additional 1,497 shares during the last quarter. Victory Capital Management Inc. purchased a new stake in shares of Halyard Health during the first quarter valued at approximately $153,000. LS Investment Advisors LLC grew its holdings in shares of Halyard Health by 16.1% during the second quarter. LS Investment Advisors LLC now owns 4,017 shares of the medical instruments supplier’s stock valued at $158,000 after buying an additional 556 shares during the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of Halyard Health by 102.5% during the first quarter. Tower Research Capital LLC TRC now owns 4,836 shares of the medical instruments supplier’s stock valued at $184,000 after buying an additional 2,448 shares during the last quarter. Finally, Blair William & Co. IL purchased a new stake in shares of Halyard Health during the first quarter valued at approximately $209,000. Hedge funds and other institutional investors own 91.02% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Halyard Health, Inc. (HYH) Stake Raised by TIAA CREF Investment Management LLC” was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://ledgergazette.com/2017/10/10/halyard-health-inc-hyh-stake-raised-by-tiaa-cref-investment-management-llc.html.

A number of equities research analysts have recently commented on HYH shares. BidaskClub upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a report on Saturday, August 19th. Deutsche Bank AG increased their price target on shares of Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a report on Thursday, August 3rd. Zacks Investment Research cut shares of Halyard Health from a “buy” rating to a “sell” rating in a report on Wednesday, October 4th. Stifel Nicolaus reiterated a “buy” rating and set a $45.00 price target on shares of Halyard Health in a report on Thursday, September 21st. Finally, Stephens upgraded shares of Halyard Health from an “equal weight” rating to an “overweight” rating in a report on Thursday, August 3rd. One analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company’s stock. Halyard Health has a consensus rating of “Buy” and a consensus price target of $42.25.

Shares of Halyard Health, Inc. (NYSE HYH) opened at 44.18 on Tuesday. Halyard Health, Inc. has a 12-month low of $31.59 and a 12-month high of $46.63. The stock’s 50 day moving average is $45.21 and its 200-day moving average is $40.37. The stock has a market cap of $2.06 billion, a PE ratio of 42.48 and a beta of 1.75.

Halyard Health (NYSE:HYH) last released its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.14. The company had revenue of $399.20 million for the quarter, compared to the consensus estimate of $399.16 million. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. Halyard Health’s revenue was down .2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.45 EPS. Equities analysts expect that Halyard Health, Inc. will post $1.95 EPS for the current year.

Halyard Health Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply